neomorphinc

Solving critical problems in human health through the discovery and development of innovative new medicines against ‘undruggable targets’.

[neomorphinc @neomorphinc]

Every achievement at Neomorph begins with a great team.

[neomorphinc @neomorphinc]

Celebrating Hidetomo Imase for his dedication, passion, and outstanding contributions to our team!

[neomorphinc @neomorphinc]

Highlighting Fan Zheng for their remarkable achievements and hard work. Thank you for your commitment

[neomorphinc @neomorphinc]

Join us in celebrating Ana Dominguez-Andres for her invaluable contributions to Neomorph!

[neomorphinc @neomorphinc]

Celebrating Lisa Strong's remarkable contributions to our team. Keep up the great work!

[neomorphinc @neomorphinc]

@neomorphinc, is excited to announce a research collaboration with Biogen to discover and develop molecular glue degraders for priority targets in Alzheimer’s, rare neurological, and immunological diseases.

#targetedproteindegradation #molecularglues

https://t.co/5cumLZojAh

[neomorphinc @neomorphinc]

Celebrating Deanna Taylor! Her expertise and commitment are invaluable. We are lucky to have you, Deanna!

[neomorphinc @neomorphinc]

Neomorph Welcomes Seasoned Biotech Executive Dr. Peter Lebowitz, M.D., Ph.D. to its Board of Directors

https://t.co/heBY6HrnBg

#neomorphinc #targetedproteindegradation #molecularglues

[neomorphinc @neomorphinc]

Meet Whitney Petrilli, a dedicated member of our Chemistry team.

#EmployeeSpotlight #Neomorph

[neomorphinc @neomorphinc]

Introducing Barbara Fink! From driving innovation to fostering team spirit, she is the heartbeat of our success.

#EmployeeSpotlight

[neomorphinc @neomorphinc]

We are excited to announce that Xiaoxi Liu will be presenting at the 38th ACS National Medicinal Chemistry Symposium on Monday, June 23rd.

[neomorphinc @neomorphinc]

Neomorph wishes you a happy and healthy holiday season!

[neomorphinc @neomorphinc]

Grateful for our incredible team, the groundbreaking strides we’re making in the molecular glue space and unlocking new possibilities to shape a healthier future. This Thanksgiving, we celebrate the power of collaboration, innovation, and the endless potential of science.

[neomorphinc @neomorphinc]

Xiaoxi applies his expertise in chemical biology and medicinal chemistry to advance early platform efforts towards data-driven decisions and drive pipeline projects towards the clinic.

[neomorphinc @neomorphinc]

Honoring our nation’s heroes, past and present, for their bravery, sacrifice, and unwavering dedication. Happy Veteran’s Day. #veteransday #gratitude #service

[neomorphinc @neomorphinc]

Join us at the 6th Annual Targeted Protein Degradation Summit in Boston, MA next week! Our VP of Chemistry, Rohan Beckwith, will discuss the exciting expansion of the druggable genome using molecular glues. See you there! #TPDSummit #Biotech

[neomorphinc @neomorphinc]

A critical leader of early biology efforts, Sarah brings a team-focused philosophy, unwavering tenacity, and an infectious can-do attitude to Neomorph where she efficiently drives projects to data-driven decisions.

[neomorphinc @neomorphinc]

Are you attending the AACR International Conference on Molecular Targets and Cancer Therapeutics in Boston, MA this week? Neomorph’s VP of Molecular Sciences, Mary Matyskiela, Ph.D., will be presenting on expanding the druggable genome with molecular glues.

[neomorphinc @neomorphinc]

Walter pushes our protein degradation science by making tremendous efforts in our chemistry lab every day. In addition to being one of our talented chemists, Walter is also a great example and mentor for early-career chemists on the team.

[neomorphinc @neomorphinc]

Attending the Protein Degradation & Targeting Undruggables Congress Europe event in Basel, Switzerland next week? Neomorph’s VP of Molecular Sciences, Mary Matyskiela, will be presenting on approaches to molecular glue discovery.